• 

  Bharat Biotech's Covaxin phase 3 data shows 77.8 pc efficacy against COVID, says Lancet

  India | November 12, 2021 9:12 IST

  Recently, WHO granted emergency use listing to Covaxin enabling countries to expedite their regulatory approval to import and administer doses.

• 

  Covid lockdowns reduced bacterial diseases spread: Lancet

  India | May 28, 2021 15:47 IST

  The rapid spread of Covid-19 forced many countries to lockdown and create national containment policies leading to a significant reduction in people's movements in all countries.

• 

  One in four people experience mild side effects from Covishield COVID-19 vaccine: Lancet study

  India | April 28, 2021 16:27 IST

  One in four people experience mild, short lived systemic side effects after receiving either the COVID-19 preventive by Pfizer or AstraZeneca vaccine -- known as Covishield in India -- with headache, fatigue and tenderness the most common symptoms, according to a study published in the Lancet Infectious Diseases journal.

• 

  Covaxin phase 2 data shows vaccine safe, induces immune response: Lancet Study

  India | March 09, 2021 17:45 IST

  India's first indigenous vaccine against COVID-19, Covaxin, is safe and generates immune response without any serious side effects, according to the interim results of the phase 2 trials published in The Lancet Infectious Diseases journal. 

• 

  Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity: Lancet study

  Science | January 22, 2021 15:55 IST

  Covaxin, which is now undergoing phase-3 trials, had raised concerns among experts over its emergency approval earlier this month by India's drug regulator.

• 

  Sputnik V Russia's vaccine safe, induces antibody response in small human trials: Key takeaways

  Good News | September 04, 2020 17:17 IST

  Russia's coronavirus vaccine, Sputnik V, that was approved last month, has shown elicit antibody response with no serious adverse events in small human trials, according to preliminary results published in The Lancet journal on Friday.

• 

  'Tomorrow. Vaccines': Lancet editor creates buzz with COVID-19 vaccine tweet

  World | July 20, 2020 18:56 IST

  There was a buzz in the medical fraternity after the Medical journal The Lancet's chief editor has dropped a tweet that appears to confirm the speculation that Phase-1 clinical trial results of the Covid-19 vaccine developed by scientists at Oxford University will be published on Monday.

• 

  COVID-19 causes mild disease in most children, fatalities rare: Lancet study

  World | June 26, 2020 15:32 IST

  Majority of COVID-19 patients under 18 years old experience a mild disease, and fatalities are extremely rare, according to the first multinational study of 582 children and adolescents. 

• 

  COVID-19 patients with high stress hormone levels at greater death risk: Lancet study

  World | June 19, 2020 12:12 IST

  COVID-19 patients with extremely high levels of the stress hormone cortisol in their blood are more likely to deteriorate quickly and die, according to study led by an Indian origin researcher in the UK.

• 

  Combination of self-isolation, testing, contact tracing needed for containing pandemic: Lancet study

  World | June 17, 2020 15:46 IST

  In the absence of a vaccine or highly effective treatments for COVID-19, scientists believe that a combination of measures such as intensive testing, and contact tracing along with physical distancing and remote working are needed to contain the pandemic.

• 

  One in five people worldwide at risk of severe COVID-19: Lancet study

  World | June 16, 2020 16:01 IST

  As many as one in five people globally have underlying medical conditions that put them at an increased risk of severe COVID-19, according to a study which may help develop strategies to shield the most vulnerable individuals.

Advertisement
• 

  Lancet issues correction on study that led WHO to pause HCQ trial

  World | May 30, 2020 15:53 IST

  Medial journal The Lancet issued a correction on a large observational study that linked use of anti-malarial drug hydroxychloroquine with increased death risk in Covid-19 patients, after more than 100 scientists and medical professionals raised questions about integrity of data analysed in the study.

• 

  Hydroxychloroquine offering no benefit in COVID-19 patients: Lancet study

  World | May 22, 2020 19:14 IST

  Treatment for COVID-19 with the antimalarial drug hydroxychloroquine, either with or without the antibiotic azithromycin, offers no benefit for COVID-19 patients, according to a large observational study.

• 

  Indoor air pollution behind 1.24 lakh premature deaths in India in 2015: Report

  India | October 31, 2017 7:08 IST

  Indoor air pollution caused 1.24 lakh premature deaths in India in 2015, a report published in Lancet has said.

• 

  India had 97 million underweight children in 2016, highest in world: Lancet

  India | October 11, 2017 18:12 IST

  The study published in The Lancet journal found that 97 million of the world's moderately or severely underweight children and adolescents lived in India in 2016.

• 

  India’s child mortality rate declines since 2005 by saving 1 mn lives, still more needs to be done- Lancet

  Lifestyle | September 21, 2017 17:00 IST

  Between 2000 and 2015, 29 million children below five died of different causes in India, data by the United Nations show.

• 

  India continues to be the hot bed of diarrhoeal deaths, Lancet

  Lifestyle | June 03, 2017 13:13 IST

  More than 100,000 under-five children died due to diarrhoea in 2015 in India and it still continues to be a hotbed of diarrhoeal deaths in the world

• 

  Alcohol addiction may trigger various cancers in Indians: Lancet

  World | September 17, 2015 12:17 IST

  London: Not just harming their heart and brain, alcohol dependency may also be behind several forms of cancers among heavy drinkers in low-income countries likeIndia, researchers have warned.The new study of alcohol use in countries

• 

  Sanitation drive ineffective in improving health in rural India: Lancet

  World | October 10, 2014 11:12 IST

  Washington: Total Sanitation Campaign - the world's largest sanitation initiative in India - provided almost 25,000 individuals in 100 rural villages in Odisha access to toilets but it did not reduce exposure to faecal pathogens